Prime Medicine Appoints Matthew Hawryluk as Chief Business Officer

Prime Medicine appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer. Hawryluk will lead corporate and business development initiatives, corporate strategy, and alliance management functions, advancing the company's efforts to expand the reach of Prime Editing through strategic partnerships and collaborations. He joins with nearly two decades of leadership experience in the biotechnology industry.